7 August 2015 - PHARMAC is seeking feedback on a proposal to fund renal multivitamin capsules (Clinicians Renal Vit capsules) resulting from a provisional agreement with Natural Health Laboratories Limited (a subsidiary of Douglas Pharmaceuticals) and PHARMAC.

In summary, this proposal would result in the listing of renal multivitamin capsules (Clinicians Renal Vit) in Section B and Part II of Section H of the Pharmaceutical Schedule from 1 October 2015. Funding would be restricted to patients with chronic kidney disease (CKD) who are on dialysis or with CKD Grade 5.

The proposal would also result in pricing being added to the existing listing in Part II of Section H for a multivitamin and mineral supplement which is restricted to patients with burns and other criteria.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2015-08-07-renal-multivitamin/